Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production. (Q53276513)
Jump to navigation
Jump to search
scientific article published on 10 January 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production. |
scientific article published on 10 January 2011 |
Statements
Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production. (English)
1 reference
Jiro Toyonaga
1 reference
Kazuhiko Tsuruya
1 reference
Hirofumi Ikeda
1 reference
Hideko Noguchi
1 reference
Hideki Yotsueda
1 reference
Kiichiro Fujisaki
1 reference
Makoto Hirakawa
1 reference
Masatomo Taniguchi
1 reference
Kohsuke Masutani
1 reference
Mitsuo Iida
1 reference
10 January 2011
1 reference
26
1 reference
2475-2484
1 reference
8
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference